2330 related articles for article (PubMed ID: 7886008)
1. p53 and PCNA expression in malignant melanomas of the head and neck.
Girod SC; Groth W; Junk M; Gerlach KL
Pigment Cell Res; 1994 Oct; 7(5):354-7. PubMed ID: 7886008
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
Kindblom LG; Ahldén M; Meis-Kindblom JM; Stenman G
Virchows Arch; 1995; 427(1):19-26. PubMed ID: 7551341
[TBL] [Abstract][Full Text] [Related]
3. Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma.
Seregard S
J Clin Pathol; 1996 Apr; 49(4):338-42. PubMed ID: 8655713
[TBL] [Abstract][Full Text] [Related]
4. p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanoma.
Barnhill RL; Castresana JS; Rubio MP; Martin MT; Idoate M; Vazquez JJ; Thor AD
Mod Pathol; 1994 Jun; 7(5):533-5. PubMed ID: 7937717
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance.
Loggini B; Rinaldi I; Pingitore R; Cristofani R; Castagna M; Barachini P
Tumori; 2001; 87(3):179-86. PubMed ID: 11504374
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
Nylander K; Nilsson P; Mehle C; Roos G
Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma.
Alaeddini M; Etemad-Moghadam S
J Oral Pathol Med; 2015 Mar; 44(3):234-8. PubMed ID: 25048051
[TBL] [Abstract][Full Text] [Related]
8. p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors.
Gelsleichter L; Gown AM; Zarbo RJ; Wang E; Coltrera MD
Mod Pathol; 1995 Jun; 8(5):530-5. PubMed ID: 7675773
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of p53, PCNA, and TGF-alpha proteins in formaldehyde-induced rat nasal squamous cell carcinomas.
Wolf DC; Gross EA; Lyght O; Bermudez E; Recio L; Morgan KT
Toxicol Appl Pharmacol; 1995 May; 132(1):27-35. PubMed ID: 7747282
[TBL] [Abstract][Full Text] [Related]
10. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer.
Grabenbauer GG; Steininger H; Meyer M; Fietkau R; Brunner T; Heinkelmann P; Hornung J; Iro H; Spitzer W; Kirchner T; Sauer R; Distel L
Radiother Oncol; 1998 May; 47(2):175-83. PubMed ID: 9683366
[TBL] [Abstract][Full Text] [Related]
11. P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer.
Wiethege T; Voss B; Müller KM
J Cancer Res Clin Oncol; 1995; 121(6):371-7. PubMed ID: 7797603
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
Park HR; Park YK
J Korean Med Sci; 1995 Oct; 10(5):360-7. PubMed ID: 8750062
[TBL] [Abstract][Full Text] [Related]
13. p53 immunoreactivity in human malignant melanoma and dysplastic naevi.
McGregor JM; Yu CC; Dublin EA; Barnes DM; Levison DA; MacDonald DM
Br J Dermatol; 1993 Jun; 128(6):606-11. PubMed ID: 8338744
[TBL] [Abstract][Full Text] [Related]
14. The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.
Björk-Eriksson T; West CM; Cvetskovska E; Svensson M; Karlsson E; Magnusson B; Slevin NJ; Edström S; Mercke C
Br J Cancer; 1999 Jul; 80(9):1400-4. PubMed ID: 10424742
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferation markers in predicting metastases in malignant melanoma.
Reddy VB; Gattuso P; Aranha G; Carson HJ
J Cutan Pathol; 1995 Jun; 22(3):248-51. PubMed ID: 7593819
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index.
Gorgoulis V; Zoumpourlis V; Rassidakis G; Karameris A; Barbatis C; Spandidos DA; Kittas C
Virchows Arch; 1995; 426(4):339-44. PubMed ID: 7599785
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
19. Localization of p53 and proliferating cell nuclear antigen in fine-needle aspirates of benign and primary malignant tumors of the human breast: an immunocytochemical study using supersensitive monoclonal antibodies and the biotin-streptavidin-amplified method.
Alexiev BA
Diagn Cytopathol; 1996 Nov; 15(4):277-81. PubMed ID: 8982580
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of PCNA, Ki67, AgNOR and p53 expression in brain glial tumors].
Berny W; Weiser A; Markowska-Woyciechowska A; Jarmundowicz W; Zub W; Załuski R
Neurol Neurochir Pol; 2004; 38(6):457-63. PubMed ID: 15654669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
